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276Abnormally high failure rate for femoral angioplasty
in patients with pseudoxanthoma elasticum
Myriam Ammi, MD,a Guido Kranenburg, MD,b Loukman Omarjee, MD,c Ludovic Martin, MD, PhD,d
Wilko Spiering, MD, PhD,b and Georges Lefthériotis, MD, PhD,c Angers, France; and Utrecht, The Netherlands
Pseudoxanthoma elasticum (PXE) is an inherited disease characterized by skin lesions, central blindness, and progressive
peripheral occlusive disease. Severe claudication is a frequent symptom for which angioplasty represents a possible
therapeutic avenue. We report the outcomes of four patients with PXE treated by angioplasty and stenting of the su-
perﬁcial femoral artery in two centers. These patients exhibited an abnormal failure rate for angioplasty and stenting of
the superﬁcial femoral artery, suggesting an as yet unknown susceptibility in such patients. In the absence of further
evidence, we do not recommend arterial angioplasty with stenting as a primary surgical approach in PXE patients with
femoral artery lesions. (J Vasc Surg Cases 2015;1:276-8.)Three women and one man with pseudoxanthoma
elasticum (PXE) diagnosed previously on the basis of skin
lesions, angioid streaks, skin biopsy,1 and genotyping
were referred for intravascular procedures for peripheral ar-
tery obstructive disease (PAOD). They suffered from se-
vere intermittent claudication with walking distances
of <250 m, and medical attempts to treat PAOD had failed
in each case. All patients gave their informed consent to
publication of this report.
CASE REPORTS
Patient 1 (a woman, 68 years old) was diagnosed with PXE at
18 years of age. She was referred with a long history of lower limb
claudication with an ankle-brachial pressure index (ABI) at rest of
0.69 on the right and 0.85 on the left. Duplex scan disclosed bilat-
eral calciﬁed short stenosis (>70%) of the superﬁcial femoral ar-
teries (SFAs). Primary angioplasty with stenting of the right SFA
was performed (Fig 1), followed 2 days later by angioplasty using
a nitinol stent (LifeStent; Bard, Tempe, Ariz) on the left side. The
patient was discharged with combined oral antiplatelet medication
(aspirin and clopidogrel). Four weeks later, intermittent claudica-
tion recurred, and duplex scanning disclosed bilateral thrombosis
of the stented SFAs. The patient is currently stable and does not
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://dx.doi.org/10.1016/j.jvsc.2015.10.001Patient 2 (a woman, 65 years old) was diagnosed with PXE at
20 years of age. She was referred for severe claudication of the left
leg (<150m)with anABI of 0.51 and 0.68on the right.Duplex scans
disclosed signiﬁcant stenosis (>70%)of the left SFA, and angioplastyof
the left SFA with a nitinol stent (LifeStent; Bard) was performed after
failure ofmedical treatment.One day later, duplex scanning conﬁrmed
reocclusion (ABI, 0.46) of the stented SFA. After patency was recov-
eredbyﬁbrinolysis (Fig2), a secondstentwasdeployed, and thepatient
was discharged initially with low-molecular-weight heparin and clopi-
dogrel. She was later switched to ticagrelor alone. A month later, the
intermittent claudication recurred, and occlusion of the stented artery
was evidenced by duplex scan. A femoral-popliteal saphenous bypass
was ﬁnally performed, and the patient has remained asymptomatic.
Patient 3was diagnosedwith PXE at 8 years of age. At 38 years, the
patient underwent her ﬁrst angioplasty with stenting (S.M.A.R.T. stent;
Cordis, Bridgewater, NJ) for stenosis of the right SFA. The patient was
discharged with phenprocoumon (3 mg). One year later, a duplex scan
disclosed a subtotal stenosis in the right SFA, which was treated by
femoral-popliteal saphenous bypass. Nine years later, her claudication
worsened on the left leg, and angioplasty of the SFA was performed.
Twelve months later, in-stent stenosis of the left SFA was found, again
treated by angioplasty. After 6 months, she was still suffering from clau-
dicationandwas referredﬁnally fora femoral-popliteal saphenousbypass.
Patient 4 was diagnosed with PXE at 41 years of age. At
44 years, he complained of severe claudication, and duplex scans
showed severe stenosis of both SFAs. Bilateral angioplasty with
stenting (S.M.A.R.T. stent; Cordis) was performed, and he was
discharged with aspirin (80 mg/d). Three years later, his
maximum walking distance had decreased; duplex scans revealed
restenosis on both sides, and bilateral angioplasty was repeated.
Restenosis of the right SFA was found shortly after, and a third an-
gioplasty was performed. Three years later, his maximum walking
distance had declined further (<150 m), and computed tomogra-
phy angiography revealed signiﬁcant restenosis of the left SFA.
Since the patient had developed a dense network of collaterals in
both legs, a watch and wait policy was decided.
DISCUSSION
PXE is a rare autosomal recessive inherited disorder
(1/25,000) characterized by abnormal calciﬁed elastic
Fig 1. Intraoperative angiography demonstrating stenosis of the
left superﬁcial femoral artery (SFA) and the result after angioplasty
and stenting.
Fig 2. Angiography showing acute superﬁcial femoral artery
(SFA) thrombosis and result after intra-arterial in situ
thrombolysis.
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teries, leading to premature PAOD. The lesions
develop mainly in the femoral segments, starting at ayoung age with long-lasting symptoms of claudication.2
For unestablished reasons, PXE disease predominates in
woman.
The treatment of PAOD in PXE currently remains
empirical, and there are few reports on endovascular treat-
ment. Donas et al performed balloon angioplasty for
infrarenal aortic and iliac stenosis in one PXE patient, still
patent at 12 months’ of follow-up.3 Siskos et al reported
6 months of patency after angioplasty with stenting at
the iliac level in a 58-year-old patient.4 Zimmo et al also re-
ported patency after endovascular surgery in a PXE patient
treated for a renal artery aneurysm.5
We here describe four patients with PXE treated with
angioplasty and stenting for the early development of
SFA stenosis. Angioplasty was decided as the ﬁrst option af-
ter all medical treatment had failed (ie, management of car-
diovascular risk factors, daily walking training). All
procedures failed because of either thrombosis (two pa-
tients) or restenosis (two patients). Catheterization was
performed by experienced operators according to conven-
tional techniques, and no speciﬁc technical problems
occurred, patency being conﬁrmed with ﬁnal angiography
after stenting. Although oral antiplatelet therapy was
administered postoperatively as recommended for this
type of procedure, the follow-up with ultrasound examina-
tion was not identical in both centers. The lack of a rela-
tionship between claudication and arterial occlusion after
angioplasty might explain the different time intervals in
detecting patency failure.
Given the rarity of the disease, the reasons for this
abnormal rate and repeated failures in patients from two
different centers suggest speciﬁc traits in the arterial remod-
eling after stenting in PXE. The early thrombosis despite
antiplatelet treatment in two patients suggests a prothrom-
botic propensity, although standard tests did not reveal ab-
normalities in coagulation and hemostasis or increased
inﬂammatory state (high-sensitivity C-reactive protein).
Hypocoagulability is more often reported in PXE.5 In the
general population, the 12-month’ patency of the SFA
with nitinol stenting reached 76.1%.6 Therefore, the
chance that the rate of occlusion in PXE in two different
centers would be 100% is very unlikely. Although a bypass
represents an alternative to angioplasty, the fact that the
calciﬁcation process could develop in a graft cannot be
excluded.
CONCLUSIONS
On the basis of our experience and in the absence of
further studies to elucidate the cause of such an abnormal
failure rate, we do not recommend angioplasty and stenting
of the SFA as a primary method for treatment of claudica-
tion in PXE.REFERENCES
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